Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Responds To Pioneer ACO Concerns About Meeting Quality Measures

This article was originally published in The Pink Sheet Daily

Executive Summary

CMS says it will expect Pioneer ACOs to meet quality performance benchmarks in 2013 based on actual Medicare fee-for-service and Medicare Advantage performance data. The ACOs had requested a delay.

You may also be interested in...



Pfizer Sales Force “Reset” Recognizes Realities Of ACO World, Exec Says

Drug company sales forces have an opportunity to play a larger role in assisting ACO organizations to achieve their goals, Pfizer’s John Zgombic pointed out, because focusing only on a transactional sale with the physician “is no longer valid.”

Pioneer ACOs Raise Concerns About Meeting Quality Measures

The ACOs say they should only be held to reporting data to CMS on the quality measures tied to the program this year, rather than be expected to necessarily meet the set quality thresholds, citing lack of evidence.

Medicare’s ACO Final Rule Responds To Provider Concerns, But Leaves Device Industry Dissatisfied

Although CMS’ newly finalized rule on accountable care organizations has allayed health care providers’ fears of a program too burdensome to bother with, medical device manufacturers remain worried that ACOs will curb patient access to their products.

Topics

UsernamePublicRestriction

Register

ID1132956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel